0Suppliers
21Customers
1Debt Items
8Related Chains

Source-Backed Evidence Depth

Stevanato Group S.p.A. (STVN) is shown with relationship data already present in ChainSifter's database. Counts below come from stored supply-chain records and filing/source URLs where available; missing source URLs are not filled in or estimated.

23Total relationships
1Distinct source URLs
3High confidence
0.663Average confidence
2026-09-13Latest database update
ChainSifter does not infer unreported suppliers, customers, ownership, acquisitions, debt exposure, revenue dependency, or future supply-chain events on this public page.

Stevanato Group S.p.A. Suppliers

No suppliers on recordStevanato Group S.p.A. has not yet been matched to upstream suppliers in our database, or is still being processed.

Stevanato Group S.p.A. Customers

TickerNameConfidenceEvidence
JABIL-PACKAGING-SOLUTIONS-FLEX-PHILLIPS-MEDISIZE JABIL-PACKAGING-SOLUTIONS-FLEX-PHILLIPS-MEDISIZE 85% -fillable syringes), Nipro and Gerresheimer AG (bulk and ready-to-use vials and cartridges, pre-fillable syringes); • Drug Delivery Systems : SHL, Ypsomed, West Pharmaceutical Services and Becton Dic…
HRMY Harmony Biosciences Holdings, Inc. 72% Reciprocal relationship from HRMY graph: Reciprocal relationship from STVN graph: t liabilities (excluding non-current advances from customers). Net working capital represents the difference between …
HRMY Harmony Biosciences Holdings, Inc. 72% t liabilities (excluding non-current advances from customers). Net working capital represents the difference between current assets and current liabilities, excluding (i) current financial assets oth…
BALDA-GROUP BALDA-GROUP 62% manage through unevenness in order activity and lead to unanticipated fluctuations in our revenue and earnings. In addition, if those customers order our products, but fail to pay on time or at all, …
CAPITAL-MANAGEMENT-THE-GROUP CAPITAL-MANAGEMENT-THE-GROUP 62% ollows: At December 31, At December 31, 2025 2024 (EUR thousand) Trade receivables 309,772 302,655 Allowance for expected credit losses ( 7,084 ) ( 6,704 ) Total trade receivables 302,688 295,951 Tra…
CAPITAL-RESOURCES CAPITAL-RESOURCES 62% een four and five years Due beyond five years Total Borrowings (1) 117.4 196.4 79.7 11.8 405.3 Notes — 49.9 — — 49.9 Lease liabilities (2) 4.4 5.7 3.3 0.4 13.8 Other financial liabilities 1.2 — — — 1…
CONTROLLED-FOREIGN-COMPANY CONTROLLED-FOREIGN-COMPANY 62% nd to meet customer demand, all of which could have an adverse effect on our financial condition and results of operations. There can be no assurance that further unforeseen events impacting the supp…
DELAWARE-GENERAL-CORPORATION DELAWARE-GENERAL-CORPORATION 62% anies, including our licensors, competitors or potential competitors. Although we seek to protect our ownership of intellectual property rights by ensuring that our agreements with our employees, con…
DENMARK-THE-GROUP DENMARK-THE-GROUP 62% . At December 31, 2025, the Group operated 13 manufacturing facilities, consisting of: (i) ten plants dedicated to the manufacturing and assembly of bio‑pharma and healthcare products (located in Ita…
ECL-THE-GROUP ECL-THE-GROUP 62% r not to exercise the option to renew or terminate the lease. That is, it considers all relevant factors that create an economic incentive for it to exercise either the renewal or termination. Expect…
GERRESHEIMER-AG GERRESHEIMER-AG 62% -fillable syringes), Nipro and Gerresheimer AG (bulk and ready-to-use vials and cartridges, pre-fillable syringes); • Drug Delivery Systems : SHL, Ypsomed, West Pharmaceutical Services and Becton Dic…
INDIANA-FISHERS-TOWN-HALL-BUILDING-CORPORATION INDIANA-FISHERS-TOWN-HALL-BUILDING-CORPORATION 62% manage through unevenness in order activity and lead to unanticipated fluctuations in our revenue and earnings. In addition, if those customers order our products, but fail to pay on time or at all, …
IQVIA-LTD IQVIA-LTD 62% opharmaceutical and Diagnostic Solutions, and Engineering), combined with our global footprint, allow us to sell products and provide services in approximately 65 countries worldwide which we achieve…
JAPAN-CO-LTD JAPAN-CO-LTD 62% manage through unevenness in order activity and lead to unanticipated fluctuations in our revenue and earnings. In addition, if those customers order our products, but fail to pay on time or at all, …
LEASES-THE-GROUP LEASES-THE-GROUP 62% stomers Contract liabilities and advances from customers are as follows: At December 31, At December 31, 2025 2024 (EUR thousand) Contract Liabilities 10,414 16,545 Advances from customers 132,273 60…
PADUA-ITALY-THE-GROUP PADUA-ITALY-THE-GROUP 62% 51 Other current financial assets 19 10,778 1,329 Tax receivables 22 14,586 17,440 Other receivables 23 35,989 53,179 Cash and cash equivalents 130,603 98,270 943,350 879,901 Non-current assets held …
PASSIVE-FOREIGN-INVESTMENT-COMPANY PASSIVE-FOREIGN-INVESTMENT-COMPANY 62% action and has to be paid on or before the 16th day of the month following the one in which the ownership was transferred. After the changes introduced by the 2026 Italian Budget Law, the FTT rates a…
PHILLIPS-MEDISIZE-GERRESHEIMER-AG PHILLIPS-MEDISIZE-GERRESHEIMER-AG 62% , Phillips Medisize, Gerresheimer AG, and West Pharmaceutical Services; and, • Engineering : Syntegon, Korber, ATS, IMA, Brevetti CEA and Mikron. Marketing We market and sell our products both direct…
PIOMBINO-DESE-THE-GROUP PIOMBINO-DESE-THE-GROUP 62% 477,491 19,111 5,972 494,632 1,391,560 At December 31, 2024 300,192 377,492 17,840 5,886 546,992 1,248,402 At December 31, 2025, the overall increases in land and buildings, considering both the year…
STEVANATO-GROUP STEVANATO-GROUP 62% ordinary course of business, the Group enters into various arrangements with key third party suppliers. A limited number of these arrangements co ntain unconditional purchase obligations to purchase …
TECHNOLOGY-DEVELOPMENT-CORPORATION TECHNOLOGY-DEVELOPMENT-CORPORATION 62% t liabilities (excluding non-current advances from customers). Net working capital represents the difference between current assets and current liabilities, excluding (i) current financial assets oth…

Stevanato Group S.p.A. Debt Obligations

InstrumentDescriptionConfidenceEvidence
STVN-DEBT Debt stack $525.3M 90% Market cache reports total debt of $525.3M.

Stevanato Group S.p.A. Acquisitions

No acquisitions on recordNo completed or pending acquisitions found in our database for Stevanato Group S.p.A..

Stevanato Group S.p.A. Ownership

HolderNameConfidenceEvidence
STVN-OWNER-CONESTOGA-CAPITAL-ADVISORS-LLC Conestoga Capital Advisors, LLC 90% 13F overlay lists Conestoga Capital Advisors, LLC as top holder; 135 tracked holders.

Stevanato Group S.p.A. Extended Supply Chain Network

TickerNameChain IndexHopsRelationship Types
CVSI CV Sciences, Inc. 100.00 2
DYN Dyne Therapeutics, Inc. 100.00 2
XYF X Financial 100.00 2
CAH Cardinal Health, Inc. 100.00 2
ORANY ORANGE 50.00 2
HRMY Harmony Biosciences Holdings, Inc. 38.88 1 ['customer']
SPRC SciSparc Ltd. 14.78 2
TMO Thermo Fisher Scientific Inc. 14.78 2
🔐
STVN
Unlock STVN Supply Chain Data
Verified relationships include:
JABIL-PACKAGING-SOLUTIONS-FLEX-PHILLIPS-MEDISIZEJABIL-PACKAGING-SOLUTIONS…Customer85%
HRMYHarmony Biosciences Holdi…Customer72%
+19 more relationships locked
Subscribe — View plans →